entertainment -WSS

entertainment

author：knowledge 2025-09-28 01:16:36 - browse：9681

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Cholera vaccine supplies dangerously low, outbreaks surging

Wikipedia

WSS

CDC advisory group OKs chikungunya vaccine

Are embryos people? Reproductive medicine's future depends on the answer

NEJM study measures Covid brain fog, impact on IQ

Why are elite athletes different? Take a look at their microbes

Change Healthcare cyberattack shows risk of industry consolidation

The science behind Janet Jackson's pregnancy at 49

hotspot

entertainment

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Using force crossed my mind when examining a defiant young patient

Cancer drug shortages should be causing more outrage

STAT's guide to the next generation of CAR

Activists slam private health insurers over coverage restrictions

Weight bias in eating disorder treatment complicated by new weight loss drugs

Affirmative action in medical school literally saved lives

Using force crossed my mind when examining a defiant young patient

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The story of mRNA: From a loose idea to a tool that may help curb Covid

leisure time

STAT's guide to the next generation of CAR

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Why we need to separate burnout from moral injury in health care

Are embryos people? Reproductive medicine's future depends on the answer

With FDA staff opposed to Sarepta therapy, top official intervened

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

knowledge

explore

Wikipedia

focus